Semaglutide vs tirzepatide and modern obesity pharmacotherapy: comparative review
Clinical Gastroenterology and Hepatology
2024
Study summary
Comparative review of modern obesity pharmacotherapies including semaglutide and tirzepatide.
Peptides studied
Goals studied
Stack studied
Metabolic Stack
Advanced Metabolic Stack
Key findings
Tirzepatide generally achieved greater weight loss, while both agents showed strong efficacy.
Study details
Study type
review article
Journal
Clinical Gastroenterology and Hepatology
DOI / PubMed
10.1016/j.cgh.2024.02.014
Year
2024
Explore peptide profiles
Discover compounds, understand their mechanisms, and explore the research behind each peptide.
